神经保护
神经炎症
创伤性脑损伤
促炎细胞因子
神经退行性变
多不饱和脂肪酸
小胶质细胞
神经生长因子
原肌球蛋白受体激酶A
医学
肿瘤坏死因子α
药理学
免疫学
炎症
癌症研究
生物
内科学
受体
生物化学
脂肪酸
疾病
精神科
作者
Long Lin,Shaorui Zheng,Jinqing Lai,Dan Ye,Qiaomei Huang,Zhe Wu,Xiangrong Chen,Shousen Wang
标识
DOI:10.1007/s12035-023-03419-3
摘要
Abstract The transformation of microglia to a pro-inflammatory phenotype at the site of traumatic brain injury (TBI) drives the progression of secondary neurodegeneration and irreversible neurological impairment. Omega-3 polyunsaturated fatty acids (PUFAs) have been shown to suppress this phenotype transformation, thereby reducing neuroinflammation following TBI, but the molecular mechanisms are unknown. We found that Omega-3 PUFA suppressed the expression of disintegrin metalloproteinase (ADAM17), the enzyme required to convert tumor necrosis factor-a (TNF-α) to the soluble form, thereby inhibiting the TNF-α/NF-κB pathway both in vitro and in a mouse model of TBI. Omega-3 PUFA also prevented the reactive transformation of microglia and promoted the secretion of microglial exosomes containing nerve growth factor (NGF), activating the neuroprotective NGF/TrkA pathway both in culture and TBI model mice. Moreover, Omega-3 PUFA suppressed the pro-apoptotic NGF/P75NTR pathway at the TBI site and reduced apoptotic neuronal death, brain edema, and disruption of the blood–brain barrier. Finally, Omega-3 PUFA preserved sensory and motor function as assessed by two broad-spectrum test batteries. The beneficial effects of Omega-3 PUFA were blocked by an ADAM17 promotor and by a NGF inhibitor, confirming the pathogenic function of ADAM17 and the central neuroprotective role of NGF. Collectively, these findings provide a strong experimental basis for Omega-3 PUFA as a potential clinical treatment for TBI.
科研通智能强力驱动
Strongly Powered by AbleSci AI